A set of basic guidelines on how to be accountable to local people and measure program impact in emergency situations. The "good enough" approach emphasizes simple and practical solutions and encourages the user to choose tools that are safe, quick, and easy to implement
En este manual hemos recopilado información sobre las caracteristicas socioculturales de inmigrantes de distintas procedencias y os presentamos las dudas más comunes que nos han planteado respecto al VIH y al sida. No obstante debemos subrayar que se trata de información orientativa y no debe lug...ar a prejuicios sino ayudarnos a entender otras maneras de ver la realidad.
more
30/03/2020 (V1) 06/04/2020 (V2)
Selon l’Organisation Mondiale de la Santé (OMS), la COVID-19 est la maladie infectieuse causée par le dernier coronavirus qui a été découvert. Ce nouveau virus était inconnu avant l’apparition de la flambée à Wuhan en Chine en décembre 2019.
Tercera versión, 1 de febrero del 2022. Estas orientaciones tienen por objetivo contribuir a que los sistemas de salud prioricen los medicamentos esenciales que deben estar disponibles y ser asequibles para manejar los pacientes en las unidades de cuidado intensivos durante las emergencias de salud.... Esta actualización incluye una sección sobre el tratamiento de pacientes graves o críticos, así como nuevos datos sobre la evidencia y la firmeza de las recomendaciones incluidas en versiones anteriores.
more
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Resistant bacteria are spreading worldwide. In collaboration with partners in India, Tanzania, South Africa and Germany, we have investigated the causes and consequences of this spread.2 This Pharma-Brief Special presents the results. It examines the risks for humans, animals and the environment. It focuses on local problems and approaches, international interactions and the re-sponsibility of doctors, farmers and consumers.
more
Orientations provisoires, 4 novembre 2020
Background paper 9
The Independent Panel for Pandemic Preparedness and Response
May 2021
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...online platform, and is updated regularly as new evidence emerges.
more
Organisation mondiale de la Santé, Organisation des Nations Unies pour l’alimentation et l’agriculture & Organisation mondiale de la santé animale. (2021). Résistance aux antimicrobiens et plan-cadre de coopération des Nations Unies pour le développement durable : orientations pour le...s équipes de pays des Nations Unies. Organisation mondiale de la Santé.
more
The frequency of infectious disease epidemics is increasing, and the role of the health sector in the management of epidemics is crucial in terms of response. In the context of infectious disease epidemics, the use of climate-informed early warning systems (EWS) has the potential to increase the eff...ectiveness of disease control by intervening before or at the beginning of the epidemic curve, instead of during the downward slope.
Currently, the initiation of interventions is heavily reliant on routine disease surveillance systems – data that often arrive too late for preventative response. However, forecasting of disease outbreaks using surveillance and weather information shows promising potential – there also remains further scope to examine seasonal climate forecasts. By combining these elements in new EWS based on computational models, it will be possible to improve both the timeliness and impact of disease control. The World Health Organization (WHO) is strengthening existing surveillance systems for infectious diseases to enable the development of more robust and timely EWS, which has resulted in the rapid development and innovation of EWS for disease outbreaks.
more
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
Europe and Central Asia Economic Update.
The Russian Federation’s war with Ukraine has triggered a catastrophic humanitarian crisis and threatened the stability of geopolitical relations. Economic output in the Europe and Central Asia region is forecast to contract by more than 4.1% in 2022—the... second major shock and regional recession in two years. Moreover, the war has added to mounting concerns of a sharp global growth slowdown.
more
Viele der derzeit in Deutschland lebenden Älteren mit Migrationsgeschichte sind im Zielland ihrer Migration unter spezifischen Bedingungen, die mit dem Migrations- und Integrationsprozess einhergehen können, älter geworden. Allerdings ist bislang wenig über diese Gruppe bekannt. Wie wirkt sich d...as biografische Ereignis „Migration“ auf die Lebensqualität, die sozioökonomische Situation und die Gesundheit im Alter aus? Welche Unterschiede gibt es zwischen der älteren Bevölkerung mit und ohne Migrationsgeschichte? Diese Research Note gibt einen Überblick über die einschlägige Forschungsliteratur. Sie beschreibt den Forschungsstand in ausgewählten Lebensbereichen und identifiziert Erkenntnislücken sowie zukünftige Forschungsfragen an der Schnittstelle Migration und Alter(n). Darüber hinaus wird die Lebenssituation älterer Menschen mit Migrationsgeschichte nicht nur dargestellt, sondern auch zugrunde liegende Ursachen für mögliche Unterschiede in den Lebensverhältnissen im Vergleich zu Gleichaltrigen ohne Migrationsgeschichte skizziert.
more
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...tries in the evidence-informed introduction and scale-up of holistic people-centred services for TB, comorbidities and health-related risk factors, with the goal of comprehensively addressing TB and other co-existing health conditions. It should be used in conjunction with relevant WHO guidelines. The Framework is intended for use by people working in ministries of health, other relevant line-ministries, policymakers, international technical and funding organizations, researchers, nongovernmental and civil society organizations, as well as primary care workers, specialist health practitioners, and community health workers who support the response to TB and comorbidities in both the public and private sectors.
more